Abstract
Background
Lymphoma is the third most common malignancy in children (0–14 years) and the first in adolescents (15–19 years). This population-based study—the largest ever done in Spain—analyses incidence and survival of lymphomas among Spanish children and adolescents.
Patients and methods
1664 lymphoma cases (1983–2007) for incidence and 1030 for survival (1991–2005) followed until 31/12/2010, were provided by 11 cancer registries. Age-adjusted incidence rates (ASRw) to the world standard population were obtained; incidence trends were modelled using the Joinpoint programme, observed survival (OS) was estimated with Kaplan–Meier and trends tested with a log-rank test. Results are presented according to the International Classification of Childhood Cancer-3.
Results
In Spain, the ASRw0–14 for lymphomas was 17.5 per 1.000.000 child-years and 50.0 the specific rate for adolescents. Overall incidence increased significantly during 1983–1997 with no increases thereafter. Patients over 9 years old showed significant rising trends for all subtypes, except for Burkitt lymphoma (BL) in adolescents. During 2001–2005 (age 0–19 years), 5-year OS was 94 (90–98), 73 (64–83) and 86 (78–94) for Hodgkin lymphoma (HL), non-Hodgkin lymphoma (NHL) and BL, respectively. No improvement in survival was found. The incidence in Spain was higher than overall European rates, but within the range of that in Southern Europe. Comparing OS in Spain 1991–1995 and 2001–2005 with results for Europe of the Automated Childhood Cancer Information System (ACCIS) (1988–1997) and the European cancer registry-based study on survival and care of cancer patients (EUROCARE) (2000–2007), it was similar for HL and lower for NHL and BL.
Conclusions
Systematic monitoring and analysis of lymphoma paediatric data would provide clinical and epidemiological information to improve the health care of these patients and the outcomes for these malignancies in Spain.
Similar content being viewed by others
References
Steliarova-Foucher E, Colombet M, Ries LAG, Moreno F, Dolya A, Bray F, et al. International incidence of childhood cancer, 2001–2010: a population-based registry study. Lancet Oncol. 2017;18(6):719–31.
Swerdlow SH, Campo E, Pileri SA, Lee Harris N, Stein H, Siebert R, et al. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016;127:2375–90.
Minard-Colin V, Brugieres L, Reiter A, Cairo MS, Gross TG, Woessmann W, et al. Non-Hodgkin lymphoma in children and adolescents: progress through effective collaboration, current knowledge, and challenges ahead. J Clin Oncol. 2015;33(27):2963–74.
Clavel J, Steliarova-Foucher E, Berger C, Danon S, Valerianova Z. Hodgkin’s disease incidence and survival in European children and adolescents (1978–1997): report from the automated cancer information system project. Eur J Cancer. 2006;42(13):2037–49.
Izarzugaza MI, Steliarova-Foucher E, Martos MC, Zivkovic S. Non-Hodgkin’s lymphoma incidence and survival in European children and adolescents (1978–1997): report from the automated childhood cancer information system project. Eur J Cancer. 2006;42(13):2050–63.
Perkins SL; Morris SW. Biology and pathology of pediatric non-Hodgkin lymphoma. In: Weinstein HJ, Hudson MM, Link MP, editors. Pediatric Lymphomas. Berlin Heidelberg: Springer; 2007. p. 91–140
Steliarova-Foucher E, Stiller C, Lacour B, Kaatsch P. International classification of childhood cancer, third edition. Cancer. 2005;103(7):1457–67.
Gatta G, Botta L, Rossi S, Aareleid T, Bielska-Lasota M, Clavel J, et al. Childhood cancer survival in Europe 1999–2007: results of EUROCARE-5—a population-based study. Lancet Oncol. 2014;15(1):35–47.
Peris-Bonet R, Salmerón D, Martínez-Beneito MA, Galceran J, Marcos-Gragera R, Felipe S, et al. Childhood cancer incidence and survival in Spain. Ann Oncol Off J Eur Soc Med Oncol. 2010;21(suppl 3):iii103–10.
Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al., editors. International classification of diseases for oncology. 3rd ed. Geneva: World Health Organization; 2000.
Instituto Nacional de Estadistica. (Spanish Statistical Office). http://www.ine.es/. Cited 05 Dec 2017
National Cancer Institute. Joinpoint regression program—surveillance research program. 2015. http://surveillance.cancer.gov/joinpoint/.
Linabery AM, Ross JA. Trends in childhood cancer incidence in the U.S. (1992–2004). Cancer. 2008;112(2):416–32.
Linet MS, Brown LM, Mbulaiteye SM, Check D, Ostroumova E, Landgren A, et al. International long-term trends and recent patterns in the incidence of leukemias and lymphomas among children and adolescents ages 0–19 years. Int J Cancer. 2016;138(8):1862–74.
Georgakis MK, Karalexi MA, Agius D, Antunes L, Bastos J, Coza D, et al. Incidence and time trends of childhood lymphomas: findings from 14 Southern and Eastern European cancer registries and the Surveillance, Epidemiology and End Results, USA. Cancer Causes Control. 2016;27(11):1381–94.
Stiller CA, Parkin DM. International variations in the incidence of childhood lymphomas. Paediatr Perinat Epidemiol. 1990;4(3):303–24.
Stiller CA, Desandes E, Danon SE, Izarzugaza I, Ratiu A, Vassileva-Valerianova Z, et al. Cancer incidence and survival in European adolescents (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):2006–18.
Ward E, DeSantis C, Robbins A, Kohler B, Jemal A. Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin. 2014;64(2):83–103.
Mcnally RJQ, Parker L. Environmental factors and childhood acute leukemias and lymphomas. Leuk Lymphoma. 2006;47(4):583–98.
Shapiro RS. Malignancies in the setting of primary immunodeficiency: implications for hematologists/oncologists. Am J Hematol. 2011;86:48–55.
Horesh N, Horowitz NA. Does gender matter in non-hodgkin lymphoma? Differences in epidemiology, clinical behavior, and therapy. Rambam Maimonides Med J. 2014;5(4):e0038.
Sankila R, Martos Jimenez MC, Miljus D, Pritchard-Jones K, Steliarova-Foucher E, Stiller C. Geographical comparison of cancer survival in European children (1988–1997): report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42(13):1972–80.
Walsh PM, Byrne J, Capra M, Comber H. Childhood cancer survival in Ireland: temporal, regional and deprivation-related patterns. Eur J Cancer. 2011;47(12):1852–62.
Schindler M, Belle FN, Grotzer MA, von der Weid NX, Kuehni CE. Childhood cancer survival in Switzerland (1976–2013): time-trends and predictors. Int J Cancer. 2017;140(1):62–74.
Karim-Kos HE, Hackl M, Mann G, Urban C, Woehrer A, Slavc I, et al. Trends in incidence, survival and mortality of childhood and adolescent cancer in Austria, 1994–2011. Cancer Epidemiol. 2016;42:72–81.
Madanat-Harjuoja LM, Pokhrel A, Kivivuori SM, Saarinen-Pihkala UM. Childhood cancer survival in Finland (1953–2010): a nation-wide population-based study. Int J Cancer. 2014;135(9):2129–34.
Pulte D, Gondos A, Brenner H. Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990–2004. J Natl Cancer Inst. 2008;100(18):1301–9.
Peris Bonet R, Pardo Romaguera E, Muñoz López A, Sayas Sanchez, Valero Poveda S. Cáncer infantil en España. Estadísticas 1980-2014. Registro Español de Tumores Infantiles (RETI-SEHOP). Valencia: Universidad de Valencia; 2017. http://www.uv.es/rnti. Accesed 18 Jul 2017.
Acknowledgements
This work was supported by FIS (PI 061742) and (PI 10/01617); Enriqueta Villavecchia Foundation; Red de Investigación Temática en Cáncer RD12/0036/0056 (RMG) and RD12/0036/0053 (RPB and JG); and CIBERESP (predoctoral contract to MS). The authors thank E Pardo and A Muñoz for their contribution to the analysis and the critic review of the manuscript.
The Spanish Childhood Cancer Epidemiology Working Group for this study includes also the following cancer registries and collaborators: Albacete (E. Almar, A. Mateos), Asturias (J. R. Quirós), Basque Country (L. Gil, A. López de Munain), Childhood Cancer Registry of the Comunitat Valenciana (C. Sabater, M. Vicente), Girona (R. Marcos-Gragera, L. Vilardell), Granada (M. Rodríguez-Barranco, D. Y. Chang), Mallorca (P. Franch, M. Ramos), Murcia (C. Navarro, M. D. Chirlaque), Navarra (M. Guevara, R. Burgui), Tarragona (M. Carulla, A. Ameijide), Zaragoza (C. Martos) and the Spanish Registry of Childhood Tumours (RETI-SEHOP) (E. Pardo, A. Muñoz).
Author information
Authors and Affiliations
Consortia
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent
For this type of study formal consent is not required.
Additional information
The members of The Spanish Childhood Cancer Epidemiology Working Group are listed in Acknowledgements section.
Rights and permissions
About this article
Cite this article
Marcos-Gragera, R., Solans, M., Galceran, J. et al. Childhood and adolescent lymphoma in Spain: incidence and survival trends over 20 years. Clin Transl Oncol 20, 1289–1301 (2018). https://doi.org/10.1007/s12094-018-1860-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-018-1860-1